21.9 USD
+0.73 (+3.45%)
21.9 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to DYN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 36.42. This target is 66.3% above the current price.
DYN was analyzed by 21 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DYN.
In the previous month the buy percentage consensus was at a similar level.
DYN was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-12 | Oppenheimer | Maintains | Perform -> Perform |
| 2025-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-10 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-08-25 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2025-08-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-31 | Stifel | Maintains | Buy -> Buy |
| 2025-07-29 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-29 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-07-15 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-06-26 | Jones Trading | Initiate | Buy |
| 2025-06-18 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-06-18 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-03-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | BMO Capital | Initiate | Outperform |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-02-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | Chardan Capital | Maintains | Buy -> Buy |
DYNE THERAPEUTICS INC / DYN FAQ
What do analysts expect the price target to be for DYNE THERAPEUTICS INC (DYN)?
21 analysts have analysed DYN and the average price target is 36.42 USD. This implies a price increase of 66.3% is expected in the next year compared to the current price of 21.9.
What is the consensus rating for DYN stock?
The consensus rating for DYNE THERAPEUTICS INC (DYN) is 81.9048 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for DYN stock?
The number of analysts covering DYNE THERAPEUTICS INC (DYN) is 21.